Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

7 Dynamite Dividend Stocks for Income and Growth in 2023

By Alex Sirois, InvestorPlace Contributor
These dividend stocks boast both impressive growth profiles and reliable dividend income for 2023 and the long-term.

Why Is Timber Pharmaceuticals (TMBR) Stock Up 61% Today?

By William White, InvestorPlace Writer
Timber Pharmaceuticals (TMBR) stock is taking off on Friday after getting an orphan drug designation for TMB-001 in Europe.

Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?

By William White, InvestorPlace Writer
Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data.

Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today?

By William White, InvestorPlace Writer
SELLAS Life Sciences (SLS) stock is falling on Friday after the biopharmaceutical company announced a proposed public offering.

Why Is Cingulate (CING) Stock Up 72% Today?

By William White, InvestorPlace Writer
Cingulate (CING) stock is on the rise Friday after releasing positive data concerning its ADHD treatment, which is in a Phase 3 trial.

7 Stocks That Just Have No Hope Left

By Louis Navellier and the InvestorPlace Research Staff
When stocks have no hope left because of a failed idea, mismanagement, bad luck or bad timing, it's time to accept they're stocks to sell.

Why Is Ocean Biomedical (OCEA) Stock Up 260% Today?

By David Moadel, InvestorPlace Contributor
OCEA stock is skyrocketing today as Ocean Biomedical highlights a promising proposed treatment for the spread of cancer cells.

3 Under-the-Radar Growth Stocks with Promising Fundamentals

By Faizan Farooque, InvestorPlace Contributor
Maximize your chances of success in the stock market by investing in these under-the-radar growth stocks that are trading at a discount.

Can Walgreens (WBA) Stock Soar 20% From Here? Why This Analyst Thinks So.

By David Moadel, InvestorPlace Contributor
WBA stock could be a high-conviction investment for 2023 as Walgreens ambitiously expands into primary healthcare.

Why Is Lucira Health (LHDX) Stock Down 34% Today?

By William White, InvestorPlace Writer
Lucira Health (LHDX) stock is taking a beating today after the company filed for Chapter 11 bankruptcy protection.

Why Is Jounce Therapeutics (JNCE) Stock Up 14% Today?

By William White, InvestorPlace Writer
Jounce Therapeutics (JNCE) stock is on the rise Thursday after the company revealed details of a merger plan with Redx Pharma.

7 Dividend Yield Monsters Poised to Soar

By Chris Lau, InvestorPlace Contributor
These high-yield dividend stocks are poised to soar as investors pile onto growing companies offering regular income.

The $75 Million Reason Sorrento (SRNE) Stock Is Moving Today

By Larry Ramer, InvestorPlace Contributor
SRNE stock is moving this morning after soaring about 25% yesterday. The company recently declared bankruptcy after losing a lawsuit.

The 3 Most Reliable Dividend Stocks for Retirees

By Ian Cooper, InvestorPlace Contributor
To recoup lost retirement savings from the 2022 pullback, many Boomers are looking into reliable dividend stocks for retirees.

Volatile SQL Stock Could Give Risk-Tolerant Investors a Wild Ride

By Louis Navellier and the InvestorPlace Research Staff
SQL stock is a fast mover, and SeqLL is an intriguing life sciences technology company that recently secured a government contract.

4 Penny Stocks for 100% Returns in 2023

By Faisal Humayun, InvestorPlace Contributor
These penny stocks look undervalued and could double over the next few quarters, due to strong business fundamentals.

Why Is OKYO Pharma (OKYO) Stock Down 19% Today?

By William White, InvestorPlace Writer
OKYO Pharma (OKYO) stock is falling on Tuesday following a recent rally as the company prepares for a presentation this week.

3 Stocks to Buy for the Future of Vertical Farming

By Alex Sirois, InvestorPlace Contributor
Vertical farming stocks cover traditional agriculture, cannabis, and lots of interesting businesses.

3 Large-Cap Biotech Stocks to Hold for the Long Haul

By John Blankenhorn, InvestorPlace Contributor
Three large-cap biotech stocks to buy and hold for the long haul
Load More Articles